How can AI help in uncertain times? 💡 will find your best ad creative. >>

The New New Thing Podcast: Marketers and Scientists Have More in Common Than You Think

Liz Prugh January 31, 2017

In this episode of The New New Thing podcast, hosts R. J. Talyor, editor-in-chief of The New New Thing, and Liz Prugh, managing editor of The New New Thing, are joined by special guest Dr. William (Bill) Scott, who serves as a research professor at IUPUI’s Department of Chemistry and Chemical Biology.

Dr. Scott’s current efforts are refinement and implementation of the Distributed Drug Discovery (D3) project at IUPUI, schools in the United States, and globally. D3 seeks to educate undergraduate students in chemistry and biology while they apply their learned skills and understanding to helping solve a serious humanitarian challenge — discovering drugs for neglected diseases. 

The group discusses experimentation as a whole, drawing several parallels to experimentation across several industries, like science, chemistry, and marketing. In this discussion, we broke down:

  • The similarities of the structure of a chemistry experiment and marketing experiment (yes — they are very much alike!)
  • Coming to terms with a failed experiment (or marketing campaign): We need to recognize the difference between failure and an unexpected observation.
  • Gaps in experimentation: Marketers, are we aware of the questions we should be asking?
  • Parallels of experimentation across industries: For example, descriptors in science are like audience interests in marketing.
  • The importance of reproducibility in experimentation — across all sectors.

You can find more about Dr. Scott’s D3 project on IUPUI’s website.

Listen to more podcasts on The New New Thing, and subscribe to our SoundCloud for updates. Follow us on Twitter and Instagram @TNNTnews.

Featured image: Drug Testing Syracuse